Eosinophilic esophagitis: Current concepts in diagnosis and management. 2024

Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
Department of Medicine, Section of Gastroenterology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

Eosinophilic esophagitis is an antigen-mediated chronic inflammatory disorder that has risen in incidence and prevalence over the past 2 decades. The clinical presentation is variable and consists of mainly esophageal symptoms such as dysphagia, heartburn, food impaction, and vomiting. Current management relies on dietary elimination, proton-pump inhibitors, and topical corticosteroids with different response rates and relapses after treatment discontinuation. With a better understanding of the underlying pathophysiology, many molecules emerged recently as targeted treatment including dupilumab (IL4/IL13 blocker), as the first FDA-approved biological treatment, which has changed the management paradigm.

UI MeSH Term Description Entries

Related Publications

Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
August 2019, World journal of gastroenterology,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
March 2020, Journal of gastrointestinal and liver diseases : JGLD,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
August 2015, Journal of pediatric gastroenterology and nutrition,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
January 2017, Allergo journal international,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
May 2020, Current problems in pediatric and adolescent health care,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
January 2017, Asia Pacific allergy,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
September 2016, Annals of the New York Academy of Sciences,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
November 2006, Current opinion in investigational drugs (London, England : 2000),
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
February 2012, Immunology and allergy clinics of North America,
Fahad I Alsohaibani, and Musthafa C Peedikayil, and Mohammed A Alzahrani, and Nahla A Azzam, and Majid A Almadi, and Evan S Dellon, and Abdulrahman A Al-Hussaini
July 2011, Journal of gastroenterology and hepatology,
Copied contents to your clipboard!